Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1883 (LINC01883) is a long intergenic non-coding RNA gene identified in the human genome. LincRNAs are a subclass of long non-coding RNAs that do not overlap with annotated protein-coding genes and are autonomously transcribed, generally longer than 200 nucleotides. The biological functions of LINC01883 specifically remain to be elucidated, but lincRNAs are broadly known to regulate gene expression through mechanisms such as chromatin modification, transcriptional control, and RNA stability. LINC01883 has been identified by integrative bioinformatic analysis as a candidate diagnostic biomarker for cancers including non-small cell lung cancer. Its expression profile may help distinguish normal from tumor tissues, though its precise cellular roles and disease mechanisms are not yet established and require experimental study. No direct drug interactions or targeted therapies are reported for this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1883 (LINC01883).